
The FDA grants accelerated approval to neladalkib for pretreated ALK-positive lung cancer, showing how next-gen kinase inhibitors tackle drug resistance
From stumbling over a journal article in a library to developing a new form of analytical technology, Sean Hart, PhD, covered an exciting journey with laser force technology.






